febit
Read, write, and understand the code of life using Microarray-based DNA detection
Success of genomics has produced an explosion of data causing inefficiencies on manual, non-automated, processes. febit is dedicated to support scientists to solve this challenge which is crucial for the understanding and learning about the Code of Life.
febit’s technology and service platform Geniom provides acadamia, medicine and industry with a revolutionary DNA analysis instrument that opens up new dimensions in flexibility and information connectivity. The automation of DNA synthesis and analysis and the superior support in bioinformatics helps to understand data and turn it into results.
Geniom is successfully used in basic and applied research of renowned institutions and companies. Geniom cutting-edge microarray technology for the analysis of genes and genomes provides superior time and cost efficiency combined with and unsurpassed spectrum of applications. Enabling both, highly integrated automation and extensive customizability, febit meets the essential needs of current biomedical research.
In the process of developing new product lines and applications based on the Geniom Platform, cooperation closely with life science researchers is an invaluable asset that stimulates numerous new ideas and approaches. For example, febit’s technology entered the high-potential markets of targeted next-generation sequencing using febit’s biochip as a filter or synthetic biology with a novel, more effective method for the production of synthetic genes. Functional interpretation and miniaturization provide a secure basis for applications in tomorrow’s molecular diagnosis.
febit was founded in 2005, and is headquartered in Lexington, Massachusetts. In-Q-Tel initially invested in febit in November 2008. For more information about febit, please visit www.febit.com.
Technology Focus Areas
- Physical and Biological Technologies
- Security
- Software and Infrastructure
